Cancer therapy-associated cardiotoxicity: A look at frailty

By sjmartinez • July 27, 2024

Hanlon E, Diaz ANR, Sedrak MS, Strom JB, Asnani A. Cancer therapy-associated cardiotoxicity: A look at frailty. J Geriatr Oncol. 2024 Jul 23:101835. doi: 10.1016/j.jgo.2024.101835. Epub ahead of print. PMID: 39048388.

Tags: anthracyclines, cardio-oncology, cardiotoxicity, Frailty, Geriatrics, heart failure, Hematology/Oncology, Publications

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm

De Botton S, Récher C, Cortes J, Curti A, Fenaux P, Peterlin P, Pigneux A, Yee K, Wei A, Mims A, Schiller G, Chao MM,[...]

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Shore N, Nielsen SM, Esplin ED, Antonarakis ES, Barata PC, Beer TM, Beltran H, Bryce A, Cookson MS, Crawford ED, Dorff TB, George DJ, Heath[...]

Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Marshalek JP, Qing X, Dragan M, Tomassetti S. Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. J Hematol. 2024 Dec;13(6):268-277.[...]